PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling von Ma, Ning, Wang, Yi-Kang, Xu, Sheng, Ni, Qian-Zhi, Zheng, Qian-Wen, Zhu, Bing, Cao, Hui-Jun, Jiang, Hao, Zhang, Feng-Kun, Yuan, Yan-Mei, Zhang, Er-Bin, Chen, Tian-Wei, Xia, Ji, Ding, Xu-Fen, Chen, Zhen-Hua, Zhang, Xiu-Ping, Wang, Kang, Cheng, Shu-Qun, Qiu, Lin, Li, Zhi-Gang, Yu, Yong-Chun, Wang, Xiao-Fan, Zhou, Bin, Li, Jing-Jing, Xie, Dong

Volltext

CHML promotes liver cancer metastasis by facilitating Rab14 recycle von Chen, Tian-Wei, Yin, Fen-Fen, Yuan, Yan-Mei, Guan, Dong-Xian, Zhang, Erbin, Zhang, Feng-Kun, Jiang, Hao, Ma, Ning, Wang, Jing-Jing, Ni, Qian-Zhi, Qiu, Lin, Feng, Jing, Zhang, Xue-Li, Bao, Ying, Wang, Kang, Cheng, Shu-Qun, Wang, Xiao-Fan, Wang, Xiang, Li, Jing-Jing, Xie, Dong

Volltext

Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis von Zhang, Er-Bin, Zhang, Xiuping, Wang, Kang, Zhang, Fengkun, Chen, Tian-Wei, Ma, Ning, Ni, Qian-Zhi, Wang, Yi-Kang, Zheng, Qian-Wen, Cao, Hui-Jun, Xia, Ji, Zhu, Bing, Xu, Sheng, Ding, Xufen, Wang, Xiang, Li, Zhigang, Cheng, Shuqun, Xie, Dong, Li, Jing-Jing

Volltext

Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation von Wang, Kang, Xiang, Yan-Jun, Yu, Hong-Ming, Cheng, Yu-Qiang, Feng, Jin-Kai, Liu, Zong-Han, Shan, Yun-Feng, Zheng, Yi-Tao, Ni, Qian-Zhi, Cheng, Shu-Qun

Volltext

Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study von Wang, Kang, Liu, Zong-Han, Yu, Hong-Ming, Cheng, Yu-Qiang, Xiang, Yan-Jun, Zhong, Jing-Ya, Ni, Qian-Zhi, Zhou, Li-Ping, Liang, Chao, Zhou, Hong-Kun, Pan, Wei-Wei, Guo, Wei-Xing, Shi, Jie, Cheng, Shu-Qun

Volltext

PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1 von Wang, Yi-Kang, Ma, Ning, Xu, Sheng, Huang, Jing-Yi, Ni, Qian-Zhi, Cao, Hui-Jun, Zheng, Qian-Wen, Zhu, Bing, Xia, Ji, Zhang, Feng-Kun, Ding, Xu-Fen, Qiu, Xiao-Song, Chen, Tian-Wei, Wang, Kang, Chen, Wei, Li, Zhi-Gang, Cheng, Shu-Qun, Xie, Dong, Li, Jing-Jing

Volltext

Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β‐catenin/TCF/LEF signalling von Gao, Hong, Yin, Fen‐Fen, Guan, Dong‐Xian, Feng, Yu‐Xiong, Zheng, Qian‐Wen, Wang, Xiang, Zhu, Min, Zhang, Xue‐Li, Cheng, Shu‐Qun, Chen, Tian‐Wei, Jiang, Hao, Zhang, Er‐Bin, Wang, Jing‐Jing, Ni, Qian‐Zhi, Yuan, Yan‐Mei, Zhang, Feng‐Kun, Ma, Ning, Cao, Hui‐Jun, Wang, Yi‐Kang, Li, Jing‐Jing, Xie, Dong

Volltext

Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis von Jiang, Hao, Cao, Hui-Jun, Ma, Ning, Bao, Wen-Dai, Wang, Jing-Jing, Chen, Tian-Wei, Zhang, Er-Bin, Yuan, Yan-Mei, Ni, Qian-Zhi, Zhang, Feng-Kun, Ding, Xu-Fen, Zheng, Qian-Wen, Wang, Yi-Kang, Zhu, Min, Wang, Xiang, Feng, Jing, Zhang, Xue-Li, Cheng, Shu-Qun, Ma, Dan-Jun, Qiu, Lin, Li, Jing-Jing, Xie, Dong

Volltext

PPDPF Promotes the Development of Mutant KRAS‐Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1 von Ni, Qian‐Zhi, Zhu, Bing, Ji, Yan, Zheng, Qian‐Wen, Liang, Xin, Ma, Ning, Jiang, Hao, Zhang, Feng‐Kun, Shang, Yu‐Rong, Wang, Yi‐Kang, Xu, Sheng, Zhang, Er‐Bin, Yuan, Yan‐Mei, Chen, Tian‐Wei, Yin, Fen‐Fen, Cao, Hui‐Jun, Huang, Jing‐Yi, Xia, Ji, Ding, Xu‐Fen, Qiu, Xiao‐Song, Ding, Kai, Song, Chao, Zhou, Wen‐Tao, Wu, Meng, Wang, Kang, Lui, Rui, Lin, Qiu, Chen, Wei, Li, Zhi‐Gang, Cheng, Shu‐Qun, Wang, Xiao‐Fan, Xie, Dong, Li, Jing‐Jing

Volltext

XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis von Xia, Ji, Ma, Ning, Shi, Qian, Liu, Qin-Cheng, Zhang, Wei, Cao, Hui-Jun, Wang, Yi-Kang, Zheng, Qian-Wen, Ni, Qian-Zhi, Xu, Sheng, Zhu, Bing, Qiu, Xiao-Song, Ding, Kai, Huang, Jing-Yi, Liang, Xin, Chen, Yu, Xiang, Yan-Jun, Zhang, Xi-Ran, Qiu, Lin, Chen, Wei, Xie, Dong, Wang, Xiang, Long, Lingyun, Li, Jing-Jing

Volltext

PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3 von Zheng, Qian-Wen, Ni, Qian-Zhi, Zhu, Bing, Liang, Xin, Ma, Ning, Wang, Yi-Kang, Xu, Sheng, Cao, Hui-Jun, Xia, Ji, Zhang, Feng-Kun, Zhang, Er-Bin, Qiu, Xiao-Song, Ding, Xu-Fen, Qiu, Lin, Zhang, Xi-Lin, Dong, Zhao-Hui, Li, Zhi-Gang, Zhang, Xue-Li, Xie, Dong, Li, Jing-Jing

Volltext

ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2 von Cao, Hui-Jun, Jiang, Hao, Ding, Kai, Qiu, Xiao-Song, Ma, Ning, Zhang, Feng-Kun, Wang, Yi-Kang, Zheng, Qian-Wen, Xia, Ji, Ni, Qian-Zhi, Xu, Sheng, Zhu, Bing, Ding, Xu-Fen, Chen, Tian-Wei, Qiu, Lin, Chen, Wei, Li, Zhi-Gang, Zhou, Bin, Feng, Wen-Ming, Xie, Dong, Li, Jing-Jing

Volltext

hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling von Cai, Zhen, Qian, Zhen-Yu, Jiang, Hao, Ma, Ning, Li, Zhi, Liu, Li-Yu, Ren, Xin-Xin, Shang, Yu-Rong, Wang, Jing-Jing, Li, Jing-Jing, Liu, Dong-Ping, Zhang, Xiu-Ping, Feng, Dan, Ni, Qian-Zhi, Feng, Yuan-Yuan, Li, Nan, Zhou, Xiao-Yan, Wang, Xiang, Bao, Ying, Zhang, Xue-Li, Deng, Yue-Zhen, Xie, Dong

Volltext

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial von Wang, Kang, Yu, Hong-Ming, Xiang, Yan-Jun, Cheng, Yu-Qiang, Ni, Qian-Zhi, Guo, Wei-Xing, Shi, Jie, Feng, Shuang, Zhai, Jian, Cheng, Shu-Qun

Volltext

NET1 promotes HCC growth and metastasis in vitro and in vivo via activating the Akt signaling pathway von Chen, Zhen-Hua, Ni, Qian-Zhi, Zhang, Xiu-Ping, Ma, Ning, Feng, Jing-Kai, Wang, Kang, Li, Jing-Jing, Xie, Dong, Ma, Xing-Yuan, Cheng, Shu-Qun

Volltext

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase 2 trial

Volltext

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3 von Zheng, Qian-Wen, Ni, Qian-Zhi, Zhu, Bing, Liang, Xin, Ma, Ning, Wang, Yi-Kang, Xu, Sheng, Cao, Hui-Jun, Xia, Ji, Zhang, Feng-Kun, Zhang, Er-Bin, Qiu, Xiao-Song, Ding, Xu-Fen, Qiu, Lin, Zhang, Xi-Lin, Dong, Zhao-Hui, Li, Zhi-Gang, Zhang, Xue-Li, Xie, Dong, Li, Jing-Jing

Volltext

Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes von Xiang, Yan-Jun, Wang, Kang, Qin, Ying-Yi, Liu, Zong-Han, Yu, Hong-Ming, Cheng, Yu-Qiang, Gu, Hong-Yi, Feng, Jin-Kai, Ni, Qian-Zhi, Zhu, Hong-Fei, Yang, Shi-Ye, Lin, En-Hua, Cai, Wen-Tao, Cheng, Dong-Hui, Tang, Yu-Fu, Zhang, Fan, Liang, Chao, Zhou, Hong-Kun, Wu, Wei, Li, Jing-Jing, Shan, Yun-Feng, Cheng, Shu-Qun

Volltext

Epithelial V‐like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB‐PI3K‐AKT pathway von Ni, QianZhi, Chen, Zhenhua, Zheng, Qianwen, Xie, Dong, Li, Jing‐Jing, Cheng, Shuqun, Ma, Xingyuan

Volltext

Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular CarcinomaSummary von Feng-Kun Zhang, Qian-Zhi Ni, Kang Wang, Hui-Jun Cao, Dong-Xian Guan, Er-Bin Zhang, Ning Ma, Yi-Kang Wang, Qian-Wen Zheng, Sheng Xu, Bing Zhu, Tian-Wei Chen, Ji Xia, Xiao-Song Qiu, Xu-Fen Ding, Hao Jiang, Lin Qiu, Xiang Wang, Wei Chen, Shu-Qun Cheng, Dong Xie, Jing-Jing Li

Volltext